Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04445493 · ClinicalTrials.gov registry record

EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID )

A clinical trial, sponsored by MindRhythm.

Completed
Registry status
486
Enrollment target

NCT04445493: Completed study, sponsored by MindRhythm.

NCT04445493 is a clinical trial that has completed, run by MindRhythm. The registered enrollment target is 486 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04445493 has completed, sponsored by MindRhythm.

COMPLETED
Registry status
486 participants
Enrollment target

Study Summary

Prehospital providers encounter patients with suspected stroke frequently. Stroke and COVID-19 are related potentially putting these healthcare workers at risk of COVID-19 infection. In addition, prehospital providers need tools to help triage large vessel stroke patients to comprehensive stroke centers.

Interventions

  • DEVICE MindRhythm Harmony

Trial Details

FieldValue
Enrollment Target 486 participants
Start Date 2021-03-01
Est. Completion 2023-01-01
MindRhythm

2 total trials

What the finished NCT04445493 record still lists

NCT04445493 is an observational study that tracks outcomes without assigning an intervention. The registered 486 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which MindRhythm Harmony is the first listed.

NCT04445493 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04445493 about?

NCT04445493 is a clinical study titled "EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID )". Prehospital providers encounter patients with suspected stroke frequently. Stroke and COVID-19 are related potentially putting these healthcare workers at risk of COVID-19 infection. In addition, prehospital providers need tools to help triage large vessel stroke patients to comprehensive stroke cen...

What is the current status of trial NCT04445493?

This trial is currently completed. The enrollment target is 486 participants. The study started on 2021-03-01. Estimated completion is 2023-01-01.

What interventions are being tested in trial NCT04445493?

The interventions under investigation include: MindRhythm Harmony (DEVICE).

Who is sponsoring clinical trial NCT04445493?

This trial is sponsored by MindRhythm, which has 2 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06420531 · 486 participants · NA

    Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

  • NCT07097142 · 486 participants · Phase 3

    Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • NCT06948435 · 487 participants · Phase 3

    A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

  • NCT06952530 · 487 participants · Phase 3

    A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04445493, the US trial registry maintained by the National Library of Medicine. NCT04445493 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.